<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04139811</url>
  </required_header>
  <id_info>
    <org_study_id>66-7/2018</org_study_id>
    <nct_id>NCT04139811</nct_id>
  </id_info>
  <brief_title>Evaluation of Visual Functions After Pars Plana Vitrectomy With and Without Internal Limiting Membrane Peeling in RRD</brief_title>
  <official_title>Evaluation of Primary Internal Limiting Membrane Peeling in Cases of Rhegmatogenous Retinal Detachment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Internal limiting membrane peeling is performed during vitrectomy for macular diseases such
      as macular holes, macular edema due to diabetic retinopathy and retinal vein occlusion.

      The incidence of epiretinal membrane formation after vitrectomy for rhegmatogenous detachment
      has been reported to range from 4.4% to 12.8%.

      In this study, the efficacy and safety of internal limiting membrane peeling will be studied
      in vitrectomy for rhegmatogenous retinal detachment and if it is essential to peel it in
      those cases or not.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      interventional observational study comparing vitrectomy with versus without internal limiting
      membrane peeling in cases of rhegmatogenous retinal detachment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 15, 2017</start_date>
  <completion_date type="Actual">August 15, 2019</completion_date>
  <primary_completion_date type="Actual">July 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>anatomical outcome</measure>
    <time_frame>6 months follow up</time_frame>
    <description>Rate of retinal reattachment using indirect ophthalmoscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>epiretinal membrane</measure>
    <time_frame>6 months follow up</time_frame>
    <description>incidence rate of epiretinal membrane formation after surgery in % percent</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>functional outcome</measure>
    <time_frame>6 months follow up</time_frame>
    <description>visual functions using log Mar Best Corrected Visual Acuity (BCVA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>superficial capillary density</measure>
    <time_frame>6 months follow up</time_frame>
    <description>measurement of percent (%) of superficial and deep capillary density using Optical Coherance Tomography Angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>multi-focal Electroretinogram</measure>
    <time_frame>6 months follow up</time_frame>
    <description>measurement of P1 amplitude</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Retinal Detachment</condition>
  <arm_group>
    <arm_group_label>non-ILM peeling group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>vitrectomy without ILM peeling is done to all cases</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ILM peeling group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>vitrectomy with ILM peeling is done to all cases</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pars Plana Vitrectomy</intervention_name>
    <description>vitrectomy with and without ILM peeling</description>
    <arm_group_label>ILM peeling group</arm_group_label>
    <arm_group_label>non-ILM peeling group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All eyes with recent macula-off rhegmatogenous retinal detachment (RRD).

        Exclusion Criteria:

          -  Complicated cases with advanced proliferative vitreoretinopathy (PVR).

          -  Patients with retinal vascular disorders and other macular disorders.

          -  Combined tractional and rhegmatogenous detachment.

          -  Previous retinal reattachment surgery or Intravitreal injections.

          -  Glaucomatous patients.

          -  Patients with corneal opacity which impairs good visualization.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>73 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed F Othman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>sub-investigator</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmed Shawkat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>sub-investigator</affiliation>
  </overall_official>
  <overall_official>
    <last_name>khalid Murad</last_name>
    <role>Principal Investigator</role>
    <affiliation>sub-investigator</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed Abdullah</last_name>
    <role>Principal Investigator</role>
    <affiliation>sub-investigator</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Minia UNiversity hospital</name>
      <address>
        <city>Minya</city>
        <state>Minia</state>
        <zip>61111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 24, 2019</study_first_submitted>
  <study_first_submitted_qc>October 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2019</study_first_posted>
  <last_update_submitted>October 23, 2019</last_update_submitted>
  <last_update_submitted_qc>October 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>Hossam Mohamed Moharram</investigator_full_name>
    <investigator_title>Assistant professor of ophthalmology</investigator_title>
  </responsible_party>
  <keyword>Internal limiting membrane</keyword>
  <keyword>multifocal electoretinogram (ERG)</keyword>
  <keyword>OCT-Angiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Detachment</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>February 20, 2020</submitted>
    <returned>March 4, 2020</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

